Sign in
HEPA Stock Price, Chart, Stats & News
Hepion Pharmaceuticals, Inc.
Save
Hepion Pharmaceuticals, Inc. (HEPA) does not currently pay a dividend.
–
Market cap
0.06x
Current P/E
–
Forward P/E
HEPA chart
1M
3M
1Y
5Y
Loading chart...
Fundamentals
Gross margin | – |
Operating margin | – |
Pretax margin | – |
Net margin | – |
Effective tax rate | – |
ROA | -269.64% |
ROE | -241.95% |
D/E | 0.02x |
Interest coverage ratio | 170.60x |
HEPA valuation
P/E | 0.06x |
P/S | – |
P/B | 0.18x |
P/CF | -0.14x |
P/FCF | -0.18x |
P/OCF | -0.14x |
PEG | -0.00x |
EV multiple | -0.29x |
About
Hepion Pharmaceuticals, Inc., a U. S.-based biopharmaceutical entity, is dedicated to developing therapeutic interventions for chronic hepatic ailments. Central to their efforts is Rencofilstat, a cyclophilin inhibitor that has successfully concluded Phase 2a clinical trials.
Similar securities
Based on sector and market capitalization
Report issue